Black Rock Inc. Vera Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,318,964 shares of VERA stock, worth $126 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,318,964

Previous 2,754,894 20.48%

Holding current value

$126 Million

Previous $42.4 Million 237.77%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$14.91 - $49.14 $8.41 Million - $27.7 Million	564,070 Added 20.48%	3,318,964 $143 Million
Q4 2023 Feb 13, 2024	BUY	$9.29 - $16.0 $3.68 Million - $6.34 Million	396,476 Added 16.81%	2,754,894 $42.4 Million
Q3 2023 Nov 13, 2023	BUY	$13.71 - $19.64 $2.58 Million - $3.7 Million	188,284 Added 8.68%	2,358,418 $32.3 Million
Q2 2023 Aug 11, 2023	BUY	$6.11 - $17.83 $4.64 Million - $13.5 Million	759,864 Added 53.88%	2,170,134 $34.8 Million
Q1 2023 May 12, 2023	BUY	$5.41 - $18.3 $2.89 Million - $9.78 Million	534,386 Added 61.01%	1,410,270 $10.9 Million

Q4 2022 Feb 13, 2023	BUY	$15.74 - $22.19 $1.34 Million - $1.89 Million	85,089 Added 10.76%	875,884 $16.9 Million
Q3 2022 Nov 14, 2022	BUY	$13.27 - $22.31 $978,808 - $1.65 Million	73,761 Added 10.29%	790,795 $16.9 Million
Q2 2022 Aug 12, 2022	BUY	$12.82 - $23.4 $478,942 - $874,200	37,359 Added 5.5%	717,034 $9.76 Million
Q1 2022 May 12, 2022	BUY	$17.8 - $28.06 $4 Million - $6.3 Million	224,575 Added 49.35%	679,675 $16 Million
Q4 2021 Feb 10, 2022	BUY	$15.01 - $35.8 $2.12 Million - $5.05 Million	141,063 Added 44.92%	455,100 $12.2 Million
Q3 2021 Nov 09, 2021	BUY	$13.71 - $30.6 $4.3 Million - $9.59 Million	313,444 Added 52857.34%	314,037 $5.45 Million
Q2 2021 Aug 11, 2021	BUY	$11.5 - $19.97 $6,819 - $11,842	593 New	593 $8,000

Others Institutions Holding VERA

# of Institutions

173

Shares Held

52.7M

Call Options Held

117K

Put Options Held

290K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.03B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account